MyPath
Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
HORIZON Research and Innovation Actions
Funded by European Health and Digital Executive Agency
1 September 2022 - 31 August 2027 (60 months)
Oslo Universitetssykehus HF, Norway
VIEW PARTNERS >
Oslo Universitetssykehus HF, Norway
Fondazione Irccs Istituto Nazionale Dei Tumori, Italy
Vrije Universiteit Brussel, Belgium
Fundación para la Investigación Del Hospital Clínico De La Comunitat Valenciana, Fundacion INCLIVA, Spain
Region Hovedstaden, Denmark
Klinikum Ernst Von Bergmann Gemeinnutzige GMBH, Germany
Fundatia Hospice Casa Sperantei, Romania
DNV IMATIS AS, Norway
European Association of Palliative Care, Belgium
European Cancer Patient Coalition, Belgium
Accelopment Schweiz AG, Switzerland
European Society for Medical Oncology, Switzerland
The University of Edinburgh, United Kingdom
University of Leeds, United Kingdom
The Leeds Teaching Hospitals National Health Service Trust, United Kingdom
Why it matters
MyPath can significantly improve the quality of and access to treatment and care, reduce variations in clinical practice, and optimise resources in family, community, and hospital care settings. This will ultimately reduce the physical, emotional, and ultimately economic burden linked to cancer.
What ECPC does
ECPC will participate in three work packages. It will be an essential contributor to co-design the structure and contents besides in the dissemination and communication of the project. ECPC will also have a major role in the coordination and the networking of the consortium.
This project is funded by the European Union under Grant Agreement No 101057514.